Use the precise reporter cell lines and assays from our manufacturer BPS Bioscience to make your research more efficient and targeted
See the difference for yourself: 83% of commercial insurance plans require prior authorization, step therapy, or both before a patient can access a GLP-1 prescribed for obesity
Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA (1997)
The emphasis of this page is therefore on catalog clarity, research-only designation, and practical logistics rather than any claim regarding biological application or outcome
[1] This glucose-dependent mechanism significantly reduces the risk of hypoglycemia when used alone, though this risk increases when combined with insulin or sulfonylureas